Metis TechBio Co Ltd, formerly Metis Technology (Hangzhou)Co Ltd is an investment holding company primarily engaged in the research and development of artificial intelligence (AI)-driven nanomaterial platform technologies. The Company's NanoForge integrated platform forms the foundation of AI-driven nanotechnology innovation system, encompassing lipid libraries, AI foundational models, METiS AI agents, quantum chemistry and molecular dynamics simulations, and AI-driven screening platforms. The Company is also engaged in the development of solution platforms, including the AI small molecule formulation design platform AiTEM, the AI nanodelivery system design platform AiLNP, and the AI messenger ribonucleic acid (mRNA) sequence design platform AiRNA. The Company primarily operates its business in the domestic market and the United States market.